Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
LIFT-AD Trial: Phase 2/3 Termination (September 2024) Despite the ACT-AD disappointment, Athira advanced to a larger phase 2/3 trial called LIFT-AD
Other parts of the protein help reduce inflammation, interact with proteins that support surrounding tissues, and regulate important repair pathways involving ILK (integrin-linked kinase) and PINCH
As there are doctors with the highest level of experience, certificates, qualifications and practical experience
Clear solution This protocol yields a clear solution of 2.75 mg/mL (saturation unknown)
Topical bioavailability: Lower but meaningful
US$ 22.62
US$ 24.39
US$ 27.05
US$ 24.98
US$ 20.22
US$ 27.66
